Bethanechol Chloride for prevention of bladder dysfunction after radical hysterectomy in gynecologic cancer patients: A Randomised controlled trial study

Completed

• Conditions: Bladder dysfunction after radical hysterectomy; Urological and Genital Diseases; Other disorders of bladder

• Registration Number: ISRCTN92687416
• Lead Sponsor: Chulalongkorn University (Thailand)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

1. Early stage cervical cancer or endometrial cancer patients who have undergone type III radical hysterectomy
2. Age 20-75 years

Exclusion Criteria

1. Hypersensitivity to bethanechol chloride
2. Active bronchial asthma
3. Hyperthyroidism
4. Hypotension
5. Tachycardia
6. Vasomotor instability
7. Coronary artery disease
8. Epilepsy
9. Parkinsonism
10. Gastrointestinal obstruction
11. Bladder neck obstruction
12. Recent urinary bladder surgery
13. Gastrointestinal resection with anastomosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified